Firefly Neuroscience (AIFF) Other Accumulated Expenses (2015 - 2024)

Firefly Neuroscience's Other Accumulated Expenses history runs 10 years deep, the most recent figure standing at $230024.0 for Q2 2024.

• On a quarterly basis, Other Accumulated Expenses fell 55.07% year-over-year to $230024.0 in Q2 2024; TTM through Jun 2024 was $230024.0, a 55.07% decrease from a year earlier, with the FY2024 full-year figure at $230024.0, changed N/A from the prior year.
• Other Accumulated Expenses improved to $230024.0 in Q2 2024 per AIFF's latest filing, from $168658.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $816536.0 in Q1 2022 and bottomed at $7656.0 in Q2 2020.
• The 5-year median for Other Accumulated Expenses is $223566.0 (2023), against an average of $274381.1.
• Across the five-year window, Other Accumulated Expenses slumped 86.3% in 2020 and surged 10047.09% in 2022, its largest moves.
• Year by year, Other Accumulated Expenses stood at $54274.0 in 2020, then surged by 276.02% to $204080.0 in 2021, then soared by 38.91% to $283497.0 in 2022, then fell by 5.61% to $267604.0 in 2023, then fell by 14.04% to $230024.0 in 2024.
• Per Business Quant, the three latest AIFF Other Accumulated Expenses figures stand at $230024.0 (Q2 2024), $168658.0 (Q1 2024), and $267604.0 (Q4 2023).